| Literature DB >> 29774171 |
Abdullah Bany Hamdan1, Abdullah Aldakhil2, Mushabbab Asiri1, Jesusa Tamani1, Sherwynn Javison1, Sheena Peethambaran1, Isamme AlFayyad3, Richard Erlandez1, Huda AlKarim1, Musa AlHarbi1.
Abstract
Background Timely treatment is a patient's right. Increasing the efficiency of laboratory testing could potentially improve hospital operations, provide quicker access to health services, and have a positive impact on patient experience. Installation of a satellite laboratory may shorten laboratory turnaround time (TAT) and chemotherapy waiting time. Method The laboratory TAT and chemotherapy waiting time were analyzed and compared before and three years after the establishment of the satellite laboratory. Result The mean laboratory TAT decreased from one hour and 30 minutes at baseline in 2012 to 43, 43, and 37 minutes in 2013, 2014, and 2015, respectively; a reduction rate of 59%. Mean chemotherapy waiting time also reduced, from a 2012 baseline of 252 minutes to 170, 157, and 146 minutes in 2013, 2014, and 2015, respectively; a reduction rate of 42%. Conclusion The reduced chemotherapy waiting time after the installation of a satellite laboratory had a positive impact on patient care. It also reduced employee workload and maximized the utilization of hospital resources.Entities:
Keywords: cancer; chemotherapy; oncology; satellite laboratory; waiting time
Year: 2018 PMID: 29774171 PMCID: PMC5955712 DOI: 10.7759/cureus.2333
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Correlation between laboratory turnaround time and chemotherapy waiting time at baseline in 2012
SD: standard deviation.
| Minimum (min) | Maximum (max) | Mean ± SD (min) | Correlation (r) | P-value | |
| Pre-intervention laboratory turnaround time | 31 | 240 | 90 ± 42 | 0.365 | *0.009 |
| Pre-intervention chemotherapy waiting time | 65 | 460 | 252 ± 77 |
Laboratory turnaround times before and after the establishment of a satellite laboratory
*Relative to pre-intervention chemotherapy laboratory TAT, 2012.
SD: standard deviation; TAT: turnaround time.
| N | Mean ± SD, min | P-value* | |
| Pre-intervention laboratory TAT, 2012 | 50 | 90 ± 42 | |
| Post-intervention laboratory TAT, 2013 | 50 | 43 ± 22 | < 0.001 |
| Post-intervention laboratory TAT, 2014 | 50 | 43 ± 14 | < 0.001 |
| Post-intervention laboratory TAT, 2015 | 50 | 37 ± 14 | < 0.001 |
Average wait time to start chemotherapy from the first blood test appointment
*Relative to pre-intervention chemotherapy waiting time, 2012
SD: standard deviation.
| N | Mean ± SD, min | P-value* | |
| Pre-intervention chemotherapy waiting time, 2012 | 150 | 252 ± 77 | |
| Post-intervention chemotherapy waiting time, 2013 | 150 | 170 ± 52 | < 0.001 |
| Post-intervention chemotherapy waiting time, 2014 | 150 | 157 ± 34 | < 0.001 |
| Post-intervention chemotherapy waiting time 2015 | 150 | 146 ± 31 | < 0.001 |